Recent talks
Beall R and panel (2021). “OADR Grant Development “Making Friends in Science” Webinar Series: Collaborating outside the academy”. Office of Grant Development, University of Calgary
Beall R (2020). “A value-based system for setting exclusivity periods for new prescription drugs“. Program on Therapeutics, Regulation and the Law, Division of Pharmacoepidemiology and Pharmacoeconomics. Harvard Medical School and Brigham and Women’s Hospital. Boston, United States.
Beall R (2019). “How will recent trade agreements impact Rx expenditures and generic access in Canada?” Centre for Health Services and Policy Research (CHSPR) Seminar Series. University of British Columbia, Vancouver, Canada.
Beall R (2019). “Pre-market development times for biologics versus small-molecule drugs”. Panelist with Mayra Vásquez and Miguel E Cortés G. in “Is data exclusivity justified? Evidence on the impacts on innovation and access to medicines”. Graduate Institute Geneva, International and Development Studies, Global Health Centre, Geneva, Switzerland.
Beall R (2019). “Patent term restoration – Why it matters for drug development and accessibility.” Institute of Health Economics, Edmonton, Canada.
Beall R (2019). “Equitable drug innovation and access.” Cumming School of Medicine and O’Brien Institute for Public Health’s Speaker Series. University of Calgary, Canada.
Beall R (2018). “Availability of generic drugs for treating rare diseases.” Program on Therapeutics, Regulation and the Law, Division of Pharmacoepidemiology and Pharmacoeconomics. Harvard Medical School and Brigham and Women’s Hospital. Boston, United States.
Beall R (2018). “Socioeconomic features of the global diffusion of pharmaceutical innovation.” American Public Health Association Annual Meeting and Expo. San Diego, United States.
Beall R (2018). “Screening and discussion of the film: ‘Drug$: The price we pay’.” Institute of Health Economics, Edmonton, Canada.
Beall R (2018). “Access to medicines, intellectual property, and global development.” Franklin Pierce Center for Intellectual Property, University of New Hampshire School of Law. Concord, United States.
Featured speaking engagements
Beall R (2016) (In)accuracy of using US and Canadian patent registers for determining medicines' patent status globally: A call for global patent transparency on essential and lifesaving medicines. United Nations Secretary-General’s High-Level Panel Hearing on Access to Medicines, London, England.
Beall R (2016) Patents and the WHO Model List of Essential Medicines (18th Edition): Clarifying the Debate on IP and Access. World Intellectual Property Organization, Geneva.
Beall R (2016) Is patent "evergreening" restricting access to device/medicine combination products? Health Technology Assessment International oral presentation. Tokyo, Japan.
Beall R (2015) Linking patent and procurement data: What do the data say? Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future. A Joint Technical Symposium by WHO, WIPO and WTO; Geneva.